KRISTINE A. ERICKSON, Ph.D, O.D.
** ***** ****** **** ( Blairstown, New Jersey 07825
978-***-**** ( *********@*****.***
DIRECTOR
Medical Affairs ( Medical Information Tracking ( Clinical Operations
Proven clinical research director with 20 years of combined experience in
project management, strategic drug development/implementation and
pharmaceutical sponsors/partners relationship-building. Adept in vendor
contract and outsourcing negotiations. Expert in grant writing and
submission process strategy development.
. Directed all aspects and phases for clinical development of novel
recombinant peptides.
. Designed and implemented preclinical and clinical programs to develop
oral recombinant peptides from preclinical toxicology studies through
phase III pivotal studies..
AREAS OF EXPERTISE
Clinical Trial Project Management ( Budget & Expense Control ( Pre-
Clinical/Clinical Development Planning
FDA Preparation ( Research Proposal Cultivation & Facilitation (
Preclinical/Clinical Data Analysis
Project Risk Management ( Regulatory Due Diligence & Compliance ( IND
Reporting
PROFESSIONAL HISTORY
Unigene Laboratories, Inc., Boonton, New Jersey ( 2007-Present
Senior Director of Clinical Affairs
Oversee and direct clinical trial executions. Manage timelines, resources
and budgets of clinical development initiatives. Draft and submit
regulatory documents, investigator brochures and IND reports. Develop
regulatory strategies to secure approval for domestic and international
marketing. Ensure compliance with SOPs, FDA regulations and ICH GCP
guidelines. Select and audit investigators, study sites, CROs, SMOs,
central labs and central imaging facilities.
Major Contributions:
. Directed Phase I-III development and implementation of oral calcitonin
in 40 months.
. Negotiated regulatory strategy with FDA for clinical trial timeline.
. Managed $33M+ in research budgets for 2 trials.
. Negotiated FDA approval of abbreviated preclinical toxicology program.
. Co-Developed regulatory strategy for marketing approval for European
Union.
Ophthalmic Research Associates, North Andover, Massachusetts ( 1996-2007
Consulting Pharmacologist/Toxicologist; Consulting Clinical Investigator
Oversaw drafting/submission of preclinical and clinical
pharmacology/toxicology sections of INDs, annual reports, protocols, and
investigator brochures. Prepared clients for FDA meetings to facilitate
approval of requests. Conducted clinical investigator training. Performed
clinical investigations for various clinical trials.
Major Contributions:
. Performed clinical assessment of dry eye via company's proprietary
environmental model.
. Conducted clinical assessment of ocular allergy via company's antigen
challenge model.
KRISTINE A. ERICKSON, Ph.D, O.D. ( Page 2 978-***-**** (
*********@*****.***
TOXIKON CORPORATION, Bedford, Massachusetts ( 2006-2007
Study Director
Directed GLP studies for development of new pharmaceutical and drug
devices. Served as sponsors' point-of-contact for strategic development of
preclinical toxicology programs for IND development. Directed research team
in execution of proof-of-concept, ADME, toxicokinetic, dose finding, acute,
subacute and chronic toxicology, and safety and genotoxicity studies.
ADDITIONAL EXPERIENCE:
Tufts University School of Medicine
Professor in Ophthalmology
. Directed NIH-funded glaucoma research program.
Boston University School of Medicine
Associate Professor in Ophthalmology and Pharmacology
. Directed NIH-funded glaucoma research program.
Harvard Medical School
Associate Professor in Ophthalmology
. Directed NIH-funded glaucoma research program.
EDUCATION & TRAINING
Optometry Residency
Boston University School of Medicine, Department of Ophthalmology, Boston,
Massachusetts
Doctor of Optometry
New England College of Optometry, Boston, Massachusetts
Doctor of Philosophy in Pharmacology
University of Wisconsin, Madison, Wisconsin
ACCREDITATION
American Academy of Optometry Fellow
AWARDS
Alcon Research Institute Award (Research Excellence) ( ASOPRS Award (
Quickert Thesis Award
ARVO Travel Fellowship ( ISER Travel Fellowship
PUBLICATIONS (Selected)
"The Perfused Human Ocular Anterior Segment as a Model for Aqueous Outflow
Physiology"
Journal of Glaucoma 1:44-53, 1992.
"Expression of adenylate cyclase subtypes II and IV in the human outflow
pathway". Invest Ophthalmol Vis Sci, 41(5);998-1005, 2000.
LICENSURE
Optometry, New Jersey, 2007-Present (inactive #27OA006123500)
Optometry, Massachusetts, 1995-2008 (#3396)